![Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy](https://www.parentprojectmd.org/wp-content/uploads/2021/09/capricor-blog.png)
Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP- 1002 - Parent Project Muscular Dystrophy
![Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association](https://strongly.mda.org/assets/uploads/2019/03/Neurogene.jpg)
Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD - Muscular Dystrophy Association
![Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place](https://assets.suredone.com/684280/media-photos/sd00002017-fuel-off-road-chrome-aftermarket-8-lug-center-cap-1002-53-cap-m-698-cap-m-721.jpg)
Fuel Off-Road Chrome Aftermarket 8-Lug Center Cap # 1002-53 CAP M-698 CAP M-721 | Premium Parts Place
![StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD) StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD)](https://yuzu-studypages-prod-east.s3.amazonaws.com/study_banners/1201.jpg)
StudyPages - A Study of Experimental Cell Therapy (CAP-1002) in Patients With Duchenne Muscular Dystrophy (DMD)
![Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X](https://biotechhealthx.com/wp-content/uploads/2021/09/Capricor-Therapeutics-To-Present-Final-HOPE-2-Trial-CAP-1002-Data-for-Late-Stage-Duchenne-Muscular-Dystrophy-DMD.jpg)
Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) • BioTech Health X
![Capricor Announces Initiation of HOPE-2 Clinical Trial Of CAP-1002 for Duchenne Muscular Dystrophy - Action Duchenne Capricor Announces Initiation of HOPE-2 Clinical Trial Of CAP-1002 for Duchenne Muscular Dystrophy - Action Duchenne](https://www.actionduchenne.org/wp-content/uploads/2019/04/getimage-17-800x500.png)